Friday, April 29, 2022

Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report

National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

ESOP Jackpot: SBI Funds IPO Unlocks Massive Wealth; 13 Employees Hit Crorepati-Mark

SBI Funds Management's stock market debut has turned years of employee stock ownership into substantial wealth, with 13 employees holdin...